PD-1 blockade in patients with advanced cutaneous squamous-cell carcinoma and concurrent chronic lymphocytic leukaemia : a case series and literature review

Eur J Dermatol. 2020 Feb 1;30(1):69-71. doi: 10.1684/ejd.2020.3710.

Authors

Julia Eglmeier¹, Dirk Debus¹, Erwin S Schultz¹

Affiliation

¹ Department of Dermatology, Paracelsus Medical University Nuremberg, City Hospital of Nuremberg, Germany.

PMID: 32250263
DOI: 10.1684/ejd.2020.3710

No abstract available

Publication types

Case Reports
Letter
Review

MeSH terms

Aged
Aged, 80 and over
Antibodies, Monoclonal, Humanized / therapeutic use
Antineoplastic Agents, Immunological / therapeutic use*
Carcinoma, Squamous Cell / drug therapy*
Carcinoma, Squamous Cell / pathology
Chemotherapy, Adjuvant
Humans
Immunocompromised Host*
Leukemia, Lymphocytic, Chronic, B-Cell / immunology*
Male
Neoplasm Recurrence, Local / drug therapy
Neoplasms, Multiple Primary / immunology*
Nivolumab / therapeutic use
Programmed Cell Death 1 Receptor / antagonists & inhibitors*
Remission Induction
Scalp / pathology
Skin Neoplasms / drug therapy*
Skin Neoplasms / pathology

Substances

Antibodies, Monoclonal, Humanized
Antineoplastic Agents, Immunological
Programmed Cell Death 1 Receptor
Nivolumab
pembrolizumab